1. Home
  2. FVCB vs TTRX Comparison

FVCB vs TTRX Comparison

Compare FVCB & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FVCBankcorp Inc.

FVCB

FVCBankcorp Inc.

HOLD

Current Price

$17.80

Market Cap

284.0M

Sector

Finance

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$8.60

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVCB
TTRX
Founded
2007
2015
Country
United States
United States
Employees
N/A
2
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.0M
281.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
FVCB
TTRX
Price
$17.80
$8.60
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$18.00
$8.00
AVG Volume (30 Days)
179.8K
100.3K
Earning Date
04-21-2026
05-31-2026
Dividend Yield
1.80%
N/A
EPS Growth
47.56
N/A
EPS
0.35
N/A
Revenue
$1,781,000.00
N/A
Revenue This Year
$13.83
N/A
Revenue Next Year
$7.45
N/A
P/E Ratio
$51.80
N/A
Revenue Growth
13.87
N/A
52 Week Low
$11.83
$2.57
52 Week High
$18.32
$11.69

Technical Indicators

Market Signals
Indicator
FVCB
TTRX
Relative Strength Index (RSI) 62.14 61.59
Support Level $15.34 $4.40
Resistance Level $17.97 $11.69
Average True Range (ATR) 0.50 1.04
MACD 0.01 0.03
Stochastic Oscillator 69.35 43.41

Price Performance

Historical Comparison
FVCB
TTRX

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: